Methotrexate Accord Healthcare

Methotrexate, the active ingredient in Methotrexate Accord Healthcare, is an antimetabolite (folate antagonist) presented as a formulation for intra‑arterial, intramuscular, and intrathecal use. It is employed in the treatment of certain cancers, autoimmune disorders, and ectopic pregnancy.

GNH USA supplies Methotrexate Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The company adheres to EU quality standards and provides reliable global distribution.

Methotrexate is used in several oncologic and autoimmune disease pathways, targeting rapidly dividing cells and immune modulation. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: improves skin lesions by decreasing keratinocyte proliferation. - Acute lymphoblastic leukemia: induces remission by inhibiting malignant lymphoblast growth. - Non‑Hodgkin lymphoma: contributes to tumor control through cytotoxic activity. - Breast cancer: used as part of combination regimens to limit tumor cell replication. - Ectopic pregnancy: terminates trophoblastic tissue when surgical options are unsuitable.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea or vomiting - Fatigue - Mouth sores (stomatitis) - Elevated liver enzymes - Low white blood cell count (leukopenia)

Serious or Rare Side Effects: - Severe liver toxicity (hepatic fibrosis or cirrhosis) - Pulmonary fibrosis or interstitial pneumonitis - Bone marrow failure leading to pancytopenia - Life‑threatening infections due to immunosuppression

When prescribing methotrexate, clinicians should observe several precautionary measures to minimize risk. - Liver monitoring: perform baseline and periodic liver function tests. - Hematologic monitoring: check complete blood counts regularly. - Renal function: adjust dose or avoid use in significant renal impairment. - Pregnancy avoidance: contraindicated in pregnancy; ensure effective contraception for both sexes. - Drug interactions: avoid concurrent use of high‑dose NSAIDs and other folate antagonists. - Store at ambient temperature: keep in original container, protect from moisture and light.

Methotrexate interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - NSAIDs (high‑dose): increase risk of renal toxicity and myelosuppression. - Penicillins (e.g., ampicillin): may reduce methotrexate clearance, raising serum levels. - Sulfonamides: potentiate bone marrow suppression. - Live vaccines: risk of severe infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may increase methotrexate exposure. - Azathioprine or other immunosuppressants: additive myelosuppression. - Warfarin: enhanced anticoagulant effect, monitor INR. - Trimethoprim: may increase methotrexate toxicity.